In contrast, we confirmed that MCL1 functioned as the target of miR-320a for ameliorating DDP resistance in CC, which was consistent with the previous study that miR-320a/MCL1 axis mediated the doxorubicin resistance of osteosarcoma (Zhou et al., 2018). Here, MCL1 is linked to osteosarcoma.